Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02472392
Title Study To Examine Toxicity Of Allogeneic Stem Cell Transplantation For Relapsed Or Therapy Refractory Ewings Sarcoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Louisville
Indications

medulloblastoma

Therapies

Fludarabine

Cyclophosphamide

Melphalan

Busulfan

anti-thymocyte globulin

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.